Safety of axitinib and sorafenib monotherapy for patients with renal cell carcinoma: a meta-analysis

{{article.zuoZheEn}}

PDF(412 KB)
PDF(412 KB)
Journal of Biomedical Research ›› 2018, Vol. 32 ›› Issue (1) : 30-38. DOI: 10.7555/JBR.32.20170080
Original Article

Safety of axitinib and sorafenib monotherapy for patients with renal cell carcinoma: a meta-analysis

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Journal of Biomedical Research, 2018, 32(1): 30‒38 https://doi.org/10.7555/JBR.32.20170080

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
PDF(412 KB)

Accesses

Citations

Detail
Sections
Recommended

/

〈 〉